LONDON: An ingredient in cannabis called cannabidiol or CBD has shown promise in a clinical trial as a potential new treatment for psychosis, scientists said on Friday. Scientists conducted a small trial of people with psychosis and found patients treated with CBD had lower levels of psychotic symptoms than those who received a placebo. Psychosis is characterised by paranoia and hallucinations. The study found that they were also more likely to be rated as “improved” by their psychiatrist and there were signs of better cognitive performance and functioning. The most common forms of psychosis are part of mental illnesses such as schizophrenia - which affects more than 21 million people worldwide - and bipolar disorder, but psychotic symptoms can also occur in conditions like Parkinson’s disease and alcohol or drug abuse.
The Paris school headteacher announced his decision in an email
A powerful government agency last week arrested Delhi Chief Minister Arvind Kejriwal, the founder of the Aam Aadmi Party
The United Nations said last year that more than 100,000 people had been trafficked into online scam centres in Cambodia
Russian social media channels have been flooded in the days since the shooting with appeals to help find victims
Canada has heavily relied on immigration to boost its labour force and economic growth
That compares with 3,770 for the same period last year and 4,162 for 2022, the previous record high